Recent NVNO Stock Price | NVNO Stock Predictions | |
$3.05 | +490.16% |
$18.00 |
Recent NVNO Analyst Ratings Breakdown, Making NVNO Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 1 | 1 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the NVNO stock predictions from the analysts covering enVVeno Medical Corp, we have collected all of the individual NVNO stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 1 different analysts covering NVNO (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since NVNO stock predictions may vary widely, another useful metric to consider is the median NVNO stock prediction, which represents the price at which half of the analysts
made NVNO stock predictions that were higher and half made NVNO stock predictions that were lower. This makes for a different take on the NVNO stock predictions out there, as compared to average or mean.
And that median across all the individual NVNO stock predictions was: $18.0 as of 2024-10-10.
The very highest of the NVNO stock predictions for one year price target was $18.0, while the very lowest of the NVNO stock predictions in the analyst group was
$18.0 (with a standard deviation of $0.0). Get the latest Zacks research report on NVNO — FREE
Find out: NVNO next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
BRO Stock Predictions
COWN Stock Predictions
ALG Stock Predictions
DNB Stock Predictions
LXP Stock Predictions
STZ Stock Predictions
EPAM Stock Predictions
LOMA Stock Predictions
GSBD Stock Predictions
|
|
Strong Buy (4.00 out of 4) 87th percentile
(ranked higher than approx. 87% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |